Fortress Biotech

Developing novel immunotherapy agents for cancer and inflammatory diseases

placeNew York City, New York, United States calendar_todayFounded 2006 groups187 employees language fortressbiotech.com

Registered entities

Innovation

1 patent family (1 granted) — focus: Human necessities; filing pace slowing. Cited 28 times.

YearFilings
20221

Social engagement

Social engagement: 5.4K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Private equity125%
Angel & family office125%
Bank & private debt125%

Recent activity

6 May 2026
Milestone
revenue
4 May 2026
Event
H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
Coming soon